Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Beta-endorphin Levels and Suicidal Behavior
NCT06291467Not yet recruiting
- Sponsor
- CHU Montpellier
- Start
- Mar 2024
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Montpellier. Primary endpoint: Plasma Beta-endorphin Levels at Day 7. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06291467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06291467.